Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut

Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

More In Business

TikTok Fined in Europe for Failing to Protect Children

TikTok Fined in Europe for Failing to Protect Children

Stretching Your Dollar: What to Know About Investing in an IPO

What to know about IPOs as a retail investor.

Stretching Your Dollar: Understanding Financial Compatibility

Understanding financial compatibility and finding your match.

Stretching Your Dollar: What the UAW Strike Means for Car Buyers

What the UAW strike means for consumers.

Stretching Your Dollar: Getting More Women Involved in Trade Jobs

Celebrating National Tradesmen Day

Walt Disney Says Not in Talks to Sell ABC

Walt Disney said it was not in any active discussions over the potential sale of ABC.

DoorDash to Move From NYSE to Nasdaq

DoorDash to Move From NYSE to Nasdaq

Writers, Studios May Start Negotiating Again Next Week

Striking Hollywood writers and studios could begin negotiating again next week.

Disney Says It's Not in Active Talks to Sell ABC

Walt Disney Co. said it's not in active talks to sell ABC.

Finding Educational Toys for the Right Price

The Toy Insider recently held its Holiday of Play event to display what items will be on your kids' lists for the upcoming holiday season. Michelle Castillo found some educational toys for under $50 and spoke with Laurie Schacht, chief toy officer of The Toy Insider, about what to look out for.

Load More